Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Patent
1988-11-07
1990-08-21
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
424468, A61K 922
Patent
active
049504860
ABSTRACT:
An osmotic device is disclosed comprising a first composition, and a second composition with the beneficial drug isradipine in the first composition.
REFERENCES:
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 4063064 (1977-12-01), Saunders et al.
patent: 4088864 (1978-05-01), Theeuwes et al.
patent: 4200098 (1980-04-01), Ayer et al.
patent: 4285987 (1981-08-01), Ayer et al.
patent: 4327725 (1982-05-01), Cortese et al.
patent: 4612008 (1986-09-01), Wong et al.
patent: 4723957 (1988-02-01), Magruda et al.
patent: 4764378 (1988-08-01), Keith et al.
patent: 4867969 (1989-09-01), Magruda et al.
patent: 4873086 (1989-10-01), Good et al.
Greenberg, MD, Barry et al., The Amer. Jol. of Cardiology, vol. 59, Jan. 30, 1987, pp. 70B-74B, "Hemodynamic Effects of PN 200-100 (Isradipine) in Congestive Heart Failure.".
Ayer Atul D.
Kuczynski Anthony L.
Swanson David R.
ALZA Corporation
Howe Leon R.
Mandell Edward L.
Page Thurman K.
Sabatine Paul L.
LandOfFree
Dosage form for treating cardiovascular diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dosage form for treating cardiovascular diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dosage form for treating cardiovascular diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1676364